Skip to main content

Here It Is

After much criticism and a false start, the US National Institutes of Health has established its new National Center for Advancing Translational Sciences and abolished the National Center for Research Resources. The changes came with the approval of an appropriations bill for fiscal year 2012 by Congress and the President on Friday.

NCATS will have a budget of $575 million, according to an NIH news release. That funding is "primarily a reallocation of funds from programs previously located in the NIH Office of the Director, National Human Genome Research Institute, and National Center for Research Resources." NIH adds that it is maintaining its funding ratio for basic and applied research.

NCRR's Web page lists the institutes and centers to which its programs have been moved, and says that NCRR-funded researchers should expect an e-mail from NIH with more information in the coming weeks.

The Scan

Not Kept "Clean and Sanitary"

A Food and Drug Administration inspection uncovered problems with cross contamination at an Emergent BioSolutions facility, the Wall Street Journal reports.

Resumption Recommendation Expected

The Washington Post reports that US officials are expected to give the go-ahead to resume using Johnson & Johnson's SARS-CoV-2 vaccine.

Canada's New Budget on Science

Science writes that Canada's new budget includes funding for the life sciences, but not as much as hoped for investigator-driven research.

Nature Papers Examine Single-Cell, Multi-Omic SARS-CoV-2 Response; Flatfish Sequences; More

In Nature this week: single-cell, multi-omics analysis provides insight into COVID-19 pathogenesis, evolution of flatfish, and more.